Assenagon Asset Management
MDGL icon

Assenagon Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Assenagon Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.7M Buy
124,214
+108,181
+675% +$55.4M 0.08% 183
2026
Q1 		$8.39M Buy
16,033
+10,643
+197% +$5.08M 0.01% 495
2025
Q4 		$3.14M Buy
+5,390
New +$2.75M ﹤0.01% 753
2024
Q4 		– Sell
-969
Closed -$206K – 1405
2024
Q3 		$206K Sell
969
-4,862
-83% -$1.24M ﹤0.01% 1331
2024
Q2 		$1.63M Sell
5,831
-7,127
-55% -$1.7M ﹤0.01% 972
2024
Q1 		$3.46M Sell
12,958
-6,124
-32% -$1.44M 0.01% 704
2023
Q4 		$4.42M Sell
19,082
-23,294
-55% -$4.08M 0.01% 668
2023
Q3 		$6.19M Sell
42,376
-424,390
-91% -$79.9M 0.02% 520
2023
Q2 		$108M Sell
466,766
-49,822
-10% -$13.5M 0.37% 46
2023
Q1 		$125M Buy
516,588
+392,145
+315% +$107M 0.44% 47
2022
Q4 		$36.1M Buy
124,443
+115,234
+1,251% +$11.3M 0.13% 157
2022
Q3 		$598K Hold
9,209
– – ﹤0.01% 1071
2022
Q2 		$659K Buy
+9,209
New +$677K ﹤0.01% 1173
2021
Q2 		– Sell
-16,098
Closed -$1.88M – 1327
2021
Q1 		$1.88M Buy
+16,098
New +$1.88M 0.01% 724

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management's MDGL Position: Q2 2026 in Review

Assenagon Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 675% in Q2 2026, buying an estimated $55.4M and bringing the position to 124,214 shares worth $66.7M. The position accounts for 0.08% of the portfolio, ranked #183.

Assenagon Asset Management first reported a position in MDGL in Q1 2021 and has held it in 14 quarters since. The position peaked at $125M in Q1 2023. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Assenagon Asset Management held 124,214 shares of Madrigal Pharmaceuticals worth $66.7M as of Q2 2026.
  • Assenagon Asset Management bought 108,181 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $55.4M.
  • Madrigal Pharmaceuticals made up 0.08% of Assenagon Asset Management's portfolio in Q2 2026, its #183 holding.
  • Assenagon Asset Management first reported a position in Madrigal Pharmaceuticals in Q1 2021 and has held it in 14 quarters since.
  • Assenagon Asset Management's Madrigal Pharmaceuticals position peaked at $125M in Q1 2023.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.